SCHEMBL7513664

SCHEMBL7513664

CC(CN(C)C)Cn1cc(-c2cncc(-c3cccc(Cl)c3)c2)c2cc(Cl)ccc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.59
FLT1 P17948 1/20 0.59
FLT4 P35916 1/20 0.59
PRKACA P17612 1/20 0.37
PRKACG P22612 1/20 0.37
PRKACB P22694 1/20 0.37
GRIN2B Q13224 3/20 0.37
FNTA P49354 7/20 0.36
FNTB P49356 7/20 0.36
PGGT1B P53609 1/20 0.36
GRIN1 Q05586 1/20 0.35
MAT2A P31153 1/20 0.35
KCNH2 Q12809 1/20 0.35
DYRK1A Q13627 1/20 0.35
ASH1L Q9NR48 1/20 0.34
TAAR1 Q96RJ0 1/20 0.34
STK4 Q13043 1/20 0.33
STK3 Q13188 1/20 0.33
LRRK2 Q5S007 1/20 0.33
KRAS P01116 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7987886 0.93 KDR (0.63) KDRFLT1FLT4PRKACAPRKACG
SCHEMBL7994231 0.92 KDR (0.70) KDRFLT1FLT4PRKACAPRKACG
SCHEMBL7508525 0.92 KDR (0.59) KDRFLT1FLT4PRKACAPRKACG
SCHEMBL7506521 0.91 KDR (0.60) KDRFLT1FLT4PRKACAPRKACG
SCHEMBL7552655 0.91 KDR (0.54) KDRFLT1FLT4PRKACAPRKACG
SCHEMBL7504838 0.91 KDR (0.54) KDRFLT1FLT4GRIN2BKCNH2
SCHEMBL7976429 0.86 KDR (0.78) KDRFLT1FLT4PRKACAPRKACG
SCHEMBL7553739 0.86 KDR (0.54) KDRFLT1FLT4PRKACAPRKACG
SCHEMBL7504511 0.85 KDR (0.54) KDRFLT1FLT4PRKACAPRKACG
SCHEMBL7990966 0.85 KDR (0.63) KDRFLT1FLT4PRKACAPRKACG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed